These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6163562)

  • 21. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
    Vandenbark AA; Hashim G; Offner H
    Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen.
    Holda JH; Welch AM; Swanborg RH
    Eur J Immunol; 1980 Aug; 10(8):657-9. PubMed ID: 6967418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to the induction of T cell-mediated autoimmunity correlates with lower IL 2 production.
    Mostarica-Stojković M; Ejdus-Konstantinović L; Kostić M; Lukić ML
    Adv Exp Med Biol; 1985; 186():713-20. PubMed ID: 2413733
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic resistance to the induction of experimental allergic encephalomyelitis in Lewis rats. I. Genetic analysis of an apparent mutant strain with phenotypic resistance to experimental allergic encephalomyelitis.
    Waxman FJ; Perryman LE; Hinrichs DJ; Coe JE
    J Exp Med; 1981 Jan; 153(1):61-74. PubMed ID: 6161206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
    Lider O; Reshef T; Beraud E; Ben-Nun A; Cohen IR
    Science; 1988 Jan; 239(4836):181-3. PubMed ID: 2447648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between surface marker expression and encephalitogenic potency of BP-cultured lymphocytes.
    Kira J; Itoyama Y; Goto I
    Cell Immunol; 1988 Mar; 112(1):14-26. PubMed ID: 2449977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
    Teitelbaum D; Webb C; Arnon R; Sela M
    Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
    [No Abstract]   [Full Text] [Related]  

  • 28. Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.
    Nagai Y; Akiyama K; Suzuki K; Kotani S; Watanabe Y; Shimono T; Shiba T; Kusumoto S; Ikuta F; Takeda S
    Cell Immunol; 1978 Jan; 35(1):158-67. PubMed ID: 74289
    [No Abstract]   [Full Text] [Related]  

  • 29. Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development.
    Bouwer HG; Dietsch GN; Hinrichs DJ
    Cell Immunol; 1990 Nov; 131(1):219-31. PubMed ID: 1699673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
    Hayosh NS; Simon LL; Swanborg RH
    J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.
    Tabi Z; McCombe PA; Pender MP
    Int Immunol; 1995 Jun; 7(6):967-73. PubMed ID: 7577805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of cytotoxicity with experimental allergic encephalomyelitis.
    Allbritton AR; Loan RW
    Cell Immunol; 1975 Sep; 19(1):91-8. PubMed ID: 52410
    [No Abstract]   [Full Text] [Related]  

  • 33. Myelination inhibiting and neuroelectric blocking factors in experimental allergic encephalomyelitis.
    Seil FJ; Smith ME; Leiman AL; Kelly JM
    Science; 1975 Mar; 187(4180):951-3. PubMed ID: 49925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells.
    Gonatas NK; Howard JC
    Science; 1974 Nov; 186(4166):839-41. PubMed ID: 4143378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pillars Article: The Rapid Isolation of Clonable Antigen-specific T Lymphocyte Lines Capable of Mediating Autoimmune Encephalomyelitis.
    Ben-Nun A; Wekerle H; Cohen IR
    J Immunol; 2017 May; 198(9):3384-3388. PubMed ID: 28416716
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
    Bolton C; Allsopp G; Cuzner ML
    Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct cell-mediated cytotoxicity in experimental allergic encephalomyelitis.
    Eggers AE; Hibbard CA
    J Neurol Sci; 1981 Jan; 49(1):109-16. PubMed ID: 6162919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Bitar DM; Whitacre CC
    Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acquisition of encephalitogenicity after sensitized cells are conditioned with myelin basic protein or concanavalin A.
    Levine S; Abreu SL; Sowinski R
    Cell Immunol; 1985 Feb; 90(2):599-604. PubMed ID: 2578332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demyelinating disease: an immunological model for studies of neural antigens.
    Hashim GA
    Gerontology; 1987; 33(3-4):181-6. PubMed ID: 2443426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.